The Global Irradiation Sterilization Services Market size is expected to reach $4.1 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.
Irradiation reduces or eliminates harmful pathogens, such as bacteria, parasites, and viruses, in food products. This is especially important for foods susceptible to contamination, such as meat, poultry, seafood, and fresh produce. Therefore, the food & laboratory segment would generate approximately 20.4% share of the market by 2030. Irradiation sterilization services decontaminate and sterilize laboratory equipment, glassware, and materials. This process ensures that the tools are free from any contaminants that might interfere with research results or compromise the integrity of experiments. Overall, irradiation provides an effective and efficient means of ensuring safety and quality in both the food and laboratory sectors. Some of the factors affecting the market are the increasing prevalence of healthcare-associated infections, rising number of government initiatives to curb infections and transition from reusable to disposable medical devices.
Healthcare-associated infections (HAIs) are infections that patients acquire while receiving medical treatment in healthcare facilities, such as hospitals and clinics. These infections can be caused by bacteria, viruses, fungi, or other pathogens and are often associated with surgical procedures, medical devices, or poor infection control practices. HAIs can be caused or exacerbated by contaminated medical devices and equipment. Patients and consumers have become more aware of the risks associated with HAIs and the importance of receiving care in facilities that prioritize infection control. This has led to a greater demand for sterile medical products and services. As healthcare facilities continue to invest in sterilization methods to reduce the incidence of HAIs, the market for irradiation sterilization services is expected to remain strong. Moreover, Government agencies and healthcare authorities recognize the importance of infection control and are implementing various measures to enhance public health and safety. Governments worldwide have established strict regulations and guidelines for sterilizing medical devices, pharmaceuticals, and food products to ensure public safety. Governments run public health campaigns to educate the public about the risks of infections and the importance of using sterile products. As pharmaceutical and biotechnology companies expand their portfolios to contain a broad range of products and therapies, the market for irradiation sterilization services continues to grow.
Additionally, the COVID-19 pandemic had a significant impact on the market. The pandemic increased the demand for medical equipment and supplies, including ventilators, PPE (personal protective equipment), and diagnostic tools. This, in turn, drove up the need for sterilization services to ensure the safety of these critical medical devices. The development and production of COVID-19 vaccines required stringent sterilization processes to maintain the integrity and safety of the vaccines. This led to an increased demand for sterilization services within the pharmaceutical industry. The urgency of the pandemic accelerated research into novel sterilization methods and technologies, including those that could be used to sterilize large quantities of PPE quickly and efficiently.
However, disposable medical devices are designed for single use, so they typically undergo fewer sterilization cycles than reusable devices. This reduced demand for sterilization services for disposable devices can impact the volume of business for irradiation service providers. Reusable devices often require more stringent sterilization processes due to the potential for repeated use. Irradiation sterilization, while highly effective, may be costlier than other methods like steam sterilization for some reusable devices. The shift to disposables can be driven, in part, by cost considerations. The change to disposable medical devices can disrupt the market dynamics for sterilization services. Thus, the limitation imposed by material compatibility negatively influences the market.
Based on product, the market is gamma irradiation, X-ray irradiation, and E-beam irradiation. In 2022, the gamma irradiation segment held the highest revenue share in the market. The high penetration capability of gamma irradiation, which permits the delivery of the intended radiation dosage to denser portions of a product, is an essential property. Moreover, gamma irradiation is safe, dependable, and highly effective when applied to various products with varying densities. The production and distribution process are aided by gamma irradiation, which ensures the complete sterility of the product by sterilizing both packaged goods and unprocessed materials. While sealed in their final packaging, products can be tampered with. This factor is expected to stimulate market expansion.
On the basis of application, the market is segmented into medical instruments, drug, food & laboratory, and others. The food & laboratory segment acquired a substantial revenue share in the market in 2022. Irradiation sterilization services find essential applications in the food industry and laboratory settings to ensure the safety, quality, and longevity of various products and materials. This ensures that experiments and tests are not compromised by unwanted microbial contamination. In laboratories conducting cell and tissue culture work, sterilization is critical to maintaining the purity of cell lines and preventing cross-contamination. Irradiation can sterilize culture dishes, media, and other supplies.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 1.9 Billion |
| Market size forecast in 2030 | USD 4.1 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 10.2% from 2023 to 2030 |
| Number of Pages | 187 |
| Number of Table | 270 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Product, Application, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the market is North America, Europe, Asia Pacific, and LAMEA. The Asia Pacific region covered a considerable revenue share in the market in 2022. This is due to the increased use of sterilization technology, the expansion of healthcare reforms, the development of the R&D industry, and advancements in the manufacturing of medical device technology in the region. Additionally, a large population base and increased public and private funding for infection prevention and control contribute to expanding the regional market. Also, China and India are two economically developing countries regarded as significant contributors to healthcare expenditures.
Free Valuable Insights: The Global Irradiation Sterilization Services Market size to reach USD 4.1 Billion by 2030
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include STERIS PLC, Röchling SE & Co. KG, SOTERA HEALTH COMPANY, Scapa Group Ltd., Swann-Morton Limited, SteriTek Silicon Valley, Beta-Gamma-Service GmbH & Co. KG, Taisei Kako Co., Ltd., IONISOS, SASU, E-BEAM Services, Inc.
By Application
By Product
By Geography
This Market size is expected to reach $4.1 billion by 2030.
Increasing prevalence of healthcare-associated infections are driving the Market in coming years, however, Transition from reusable to disposable medical devices restraints the growth of the Market.
STERIS PLC, Röchling SE & Co. KG, SOTERA HEALTH COMPANY, Scapa Group Ltd., Swann-Morton Limited, SteriTek Silicon Valley, Beta-Gamma-Service GmbH & Co. KG, Taisei Kako Co., Ltd., IONISOS, SASU, E-BEAM Services, Inc.
The expected CAGR of this Market is 10.2% from 2023 to 2030.
The Medical Instruments segment is leading the Market, by Application in 2022, thereby, achieving a market value of $1.3 billion by 2030.
The North America region dominated the Market, by region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1.6 billion by 2030.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
